EarliPoint Health Launches Project ALIGN to Advance Objective Measurement and Outcomes in Autism Care

Learn More →

Articles

Exploring the science, practice, and people shaping the future of early developmental evaluation.

VB-MAPP: A Complete Guide to the Verbal Behavior Milestones Assessment and Placement Program

The VB-MAPP is a criterion-referenced assessment, curriculum guide, and skill-tracking system that measures the language, learning, and social skills of children with […]

…

ABA Reauthorization Documentation: How Objective Measurement Strengthens Medical Necessity

Reauthorization is where many ABA practices quietly lose time and revenue. The clinical work is sound, the child is progressing, and the […]

…

Why Your Child With Autism Is “Brutally Honest” in Social Settings

At dinner, a relative asks how the new haircut looks in front of everyone and gets an answer no one expected. A […]

…

How to Know If Your Child’s ABA Therapy Is Working

If you’ve found yourself watching your child during a session and quietly wondering, “Is this actually helping?” — you are far from […]

…

The Hidden Cost of Subjective Assessment in ABA

Ask most ABA practice owners what an assessment costs, and they’ll quote the price of the form. That number is real, but […]

…

Subjective vs. Objective Measurement in Autism Care: Why the Field Is Shifting

Autism assessment has always relied on two trusted sources: what a trained clinician observes and what a caregiver reports. Both are rigorous, […]

…
Request A Demo

Jamie Pagliaro brings over two decades of leadership in autism and behavioral health to his role as President and CEO of EarliPoint. Most recently, he served as Chief Operating Officer at Rethink, a leading SaaS provider supporting individuals with autism and developmental disabilities. Under his leadership, Rethink’s behavioral health division became the company’s largest business unit, serving thousands of clinicians and driving scalable, tech-enabled care delivery.

Earlier in his career, Jamie was Executive Director of the New York Center for Autism Charter School, the first public charter school in New York State dedicated to children with autism. At EarliPoint, he leads the company’s mission to bring breakthrough science to the front lines of care—empowering providers, families, and health systems with earlier answers and better outcomes.

Jamie Pagliaro

President & Chief Executive Officer

Dr. Ami Klin is a globally recognized leader in autism research and early detection. As Director of the Marcus Autism Center and Division Chief of Autism and Developmental Disabilities at Emory University School of Medicine, he has dedicated his career to understanding how young children engage with the social world—and how subtle disruptions in attention can signal developmental differences. His pioneering work in eye-tracking science led to the development of EarliPoint™ Evaluation, the first FDA-authorized tool to objectively assess autism in children as young as 16 months.
At EarliPoint, Dr. Klin drives clinical strategy and innovation, ensuring that families and clinicians worldwide have access to timely, science-based insights that enable earlier, more personalized intervention. His career reflects a deep commitment to transforming how society supports children with autism—starting with the earliest signs.

Ami Klin, PhD

Chief Clinical Officer & Co‑Founder